{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:02:00Z","timestamp":1777536120070,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T00:00:00Z","timestamp":1395187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00259-014-2738-2","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T09:54:51Z","timestamp":1395136491000},"page":"1603-1616","source":"Crossref","is-referenced-by-count":20,"title":["Bispecific antibody complex pre-targeting and targeted delivery of polymer drug conjugates for imaging and therapy in dual human mammary cancer xenografts"],"prefix":"10.1007","volume":"41","author":[{"given":"Ban-An","family":"Khaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyur S.","family":"Gada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishwesh","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Panwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savitri","family":"Mandapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Hatefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stan","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Weisenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,19]]},"reference":[{"key":"2738_CR1","unstructured":"Why is early diagnosis important? \u201cLet\u2019s beat cancer sooner.\u201d Cancer Research UK. www.cancerresearchuk.org ."},{"key":"2738_CR2","unstructured":"Breast cancer: early detection. The importance of finding breast cancer early. American Cancer Society. www.cancer.org\/acs\/groups\/cid\/documents\/webcontent\/003165-pdf.pdf ."},{"key":"2738_CR3","first-page":"1358","volume":"30","author":"JM Doussal Le","year":"1989","unstructured":"Le Doussal JM, Martin M, Gautherot E, Delaage M, Barbet J. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugate: enhanced divalent hapten affinity for cell-bound antibody conjugate. J Nucl Med. 1989;30:1358\u201366.","journal-title":"J Nucl Med"},{"key":"2738_CR4","first-page":"3445","volume":"50","author":"JM Doussal Le","year":"1990","unstructured":"Le Doussal JM, Gruaz-Guyon, Martin M, Gautherot E, Delaage M, Barbet J. Targeting of Indium-111-labeled bivalent hapten to human melanoma by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. Cancer Res. 1990;50:3445\u201352.","journal-title":"Cancer Res"},{"key":"2738_CR5","first-page":"400","volume":"44","author":"O Boerman","year":"2003","unstructured":"Boerman O, Van Schaijk F, Oyen W, Corstens F. Pretargeted radioimmunotherapy of cancer: progress step by step. J Nucl Med. 2003;44:400\u201311.","journal-title":"J Nucl Med"},{"key":"2738_CR6","first-page":"19","volume":"2","author":"DM Goldenberg","year":"2007","unstructured":"Goldenberg DM, Chatal JF, Barbet J, Boerman O, Sharkey R. Cancer imaging and therapy with bispecific antibody pretargeting. Cancer Ther. 2007;2:19\u201331.","journal-title":"Cancer Ther"},{"issue":"2","key":"2738_CR7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiol.2462070229","volume":"246","author":"RM Sharkey","year":"2008","unstructured":"Sharkey RM, Karacay H, Vallabhajosula S, McBride WJ, Rossi EA, Chang C, et al. Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model. Radiology. 2008;246(2):497\u2013507.","journal-title":"Radiology"},{"key":"2738_CR8","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood-2010-03-276857","volume":"116","author":"P Gupta","year":"2010","unstructured":"Gupta P, Goldenberg DM, Rossi EA, Chang CH. Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20\/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias. Blood. 2010;116:3258\u201367.","journal-title":"Blood"},{"key":"2738_CR9","first-page":"6387","volume":"6","author":"Y Matsumura","year":"1986","unstructured":"Matsumura Y, Maeda H. A new concept for macromolecular therapies in cancer chemotherapy: mechanism of tumouritropic accumulation of proteins and the antitumour agent SMANCS. Cancer Res. 1986;6:6387\u201392.","journal-title":"Cancer Res"},{"key":"2738_CR10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0168-3659(92)90088-9","volume":"19","author":"R Duncan","year":"1992","unstructured":"Duncan R, Seymour LW, O\u2019Hare KB, Flanagan PA, Wedge S, Hume IC, et al. Preclinical evaluation of polymer bound doxorubicin. J Control Release. 1992;19:331\u201346.","journal-title":"J Control Release"},{"issue":"80","key":"2738_CR11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.addr.2007.11.009","volume":"60","author":"C Li","year":"2008","unstructured":"Li C, Wallace S. Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev. 2008;60(80):886\u201398.","journal-title":"Adv Drug Deliv Rev"},{"key":"2738_CR12","first-page":"868","volume":"47","author":"BA Khaw","year":"2006","unstructured":"Khaw BA, Tekabe Y, Johnson L. Imaging experimental atherosclerotic lesions in ApoE knockout mice: enhanced targeting with Z2D3-anti-DTPA bispecific antibody and 99mTc-labeled negatively charged polymers. J Nucl Med. 2006;47:868\u201376.","journal-title":"J Nucl Med"},{"key":"2738_CR13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/MNM.0b013e32834af77b","volume":"32","author":"K Gada","year":"2011","unstructured":"Gada K, Patil V, Panwar R, Majewski S, Tekabe Y, Khaw BA. Pretargeted gamma imaging of murine metastatic melanoma lung lesions with bispecific antibody and radiolabeled polymer drug conjugates. Nucl Med Commun. 2011;32:1231\u201340.","journal-title":"Nucl Med Commun"},{"key":"2738_CR14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1021\/bc0000379","volume":"11","author":"H Karacay","year":"2000","unstructured":"Karacay H, McBride WJ, Griffiths GL, Sharkey RM, Barbet J, Hansen HJ, et al. Experimental pretargeting studies of cancer with a humanized anti-CEA x murine ant-[In-DTPA] bispecific antibody construct and a 99mTc\/188Re-labeleld peptide. Bioconjug Chem. 2000;11:842\u201354.","journal-title":"Bioconjug Chem"},{"key":"2738_CR15","first-page":"824","volume":"39","author":"V Patil","year":"2012","unstructured":"Patil V, Gada K, Panwar R, Varvarigou A, Majewski S, Weisenberger A, et al. Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug-conjugates. EJNMMI. 2012;39:824\u201339.","journal-title":"EJNMMI"},{"key":"2738_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13346-011-0055-x","volume":"2","author":"KS Gada","year":"2012","unstructured":"Gada KS, Patil V, Panwar R, Hatefi A, Khaw BA. Bispecific antibody complex pretargeted delivery of polymer-drug-conjugates for cancer. Drug Deliv Transl Res. 2012;2:65\u201376.","journal-title":"Drug Deliv Transl Res"},{"issue":"10","key":"2738_CR17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3109\/1061186X.2013.818675","volume":"21","author":"V Patil","year":"2013","unstructured":"Patil V, Gada K, Panwar R, Majewski S, Tekabe Y, Varvarigou A, et al. In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with bombesin bispecific complexes and targeting with polymer-drug-conjugates. J Drug Target. 2013;21(10):1012\u201321.","journal-title":"J Drug Target"},{"key":"2738_CR18","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-05-3521","volume":"66","author":"A Orlova","year":"2006","unstructured":"Orlova A, Magnusson M, Eriksson TL, Nilsson M, Larson B, Hoiden-Guthenberg I, et al. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res. 2006;66:4339\u201348.","journal-title":"Cancer Res"},{"key":"2738_CR19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0003-2697(86)90231-9","volume":"155","author":"MS Bernatowicz","year":"1986","unstructured":"Bernatowicz MS, Matsueda GR. Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent. Anal Biochem. 1986;155:95\u2013102.","journal-title":"Anal Biochem"},{"key":"2738_CR20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0003-2697(66)90275-2","volume":"14","author":"AFSA Habeeb","year":"1966","unstructured":"Habeeb AFSA. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem. 1966;14:328\u201336.","journal-title":"Anal Biochem"},{"key":"2738_CR21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1006494001861","volume":"61","author":"B Clinchy","year":"2000","unstructured":"Clinchy B, Gazdar A, Rabinovsky R, Yefenof E, Gordon B, Vitetta ES. The growth and metastasis of human, HER-2\/neu-overexpressing tumor cell lines in male SCID mice. Breast Cancer Res Treat. 2000;61:217\u201328.","journal-title":"Breast Cancer Res Treat"},{"key":"2738_CR22","unstructured":"Hammond W, Tekabe Y, Johnson L, Majewski S, Popov V, Kross B, et al. Development of high performance mini gamma cameras based on LaBr3scintillator and H8500 and H9500 PSPMTs and their use in small animal studies. Medical Imaging Conference 2006."},{"key":"2738_CR23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.2930310402","volume":"31","author":"DM Euhus","year":"1986","unstructured":"Euhus DM, Hudd C, LaRegina MC, Johnson FE. Tumor measurement in the nude mouse. J Surg Oncol. 1986;31:229\u201334.","journal-title":"J Surg Oncol"},{"key":"2738_CR24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2342-8-16","volume":"8","author":"MM Jensen","year":"2008","unstructured":"Jensen MM, Jorgensen JT, Binderup T, Kjaer A. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. BMC Med Imaging. 2008;8:16\u201325.","journal-title":"BMC Med Imaging"},{"key":"2738_CR25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchromb.2004.04.030","volume":"808","author":"RD Arnold","year":"2004","unstructured":"Arnold RD, Slack JE, Straubinger RM. Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography\/electrospray tandem mass spectroscopy. J Chromatogr B. 2004;808:141\u201352.","journal-title":"J Chromatogr B"},{"key":"2738_CR26","first-page":"23","volume":"9","author":"DD Hoff Von","year":"1982","unstructured":"Von Hoff DD, Rozencweig M, Piccart M. The cardiotoxicity of anticancer agents. Semin Oncol. 1982;9:23\u201333.","journal-title":"Semin Oncol"},{"key":"2738_CR27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1096\/fasebj.11.12.9337145","volume":"11","author":"P Singal","year":"1997","unstructured":"Singal P, Iliskovic N, Li T, Kumar D. Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J. 1997;11:931\u20136.","journal-title":"FASEB J"},{"key":"2738_CR28","first-page":"742","volume":"60","author":"R Injac","year":"2008","unstructured":"Injac R, Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, et al. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress. Pharmacol Rep. 2008;60:742\u20139.","journal-title":"Pharmacol Rep"},{"key":"2738_CR29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12011-009-8377-y","volume":"132","author":"F Bulucu","year":"2009","unstructured":"Bulucu F, Ocal R, Karadurmus N, Sahin M, Kenar L, Aydin A, et al. Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity. Biol Trace Elem Res. 2009;132:184\u201396.","journal-title":"Biol Trace Elem Res"},{"key":"2738_CR30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/316354a0","volume":"316","author":"P Perez","year":"1985","unstructured":"Perez P, Hoffman RW, Shaw S, Bluestone JA, Segal DM. Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody. Nature. 1985;316:354\u20136.","journal-title":"Nature"},{"key":"2738_CR31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2967\/jnumed.110.083568","volume":"52","author":"H Karacay","year":"2001","unstructured":"Karacay H, Sharkey RM, McBride WJ, Rossi EA, Chang CH, Goldenberg DM. Optimization of Hapten-peptide labeling for pretargeted immune-PET of bispecific antibody using generated-produced 68Ga. J Nucl Med. 2001;52:555\u20139.","journal-title":"J Nucl Med"},{"key":"2738_CR32","first-page":"223","volume":"4","author":"AJ Baumgarten","year":"2007","unstructured":"Baumgarten AJ, Fiebig HH, Burger AM. Molecular analysis of xenografted models of human cancer cachexia: possibilities for therapeutic intervention. Cancer Genomics Proteomics. 2007;4:223\u201332.","journal-title":"Cancer Genomics Proteomics"},{"issue":"4","key":"2738_CR33","first-page":"281","volume":"11","author":"L Mazzanti","year":"1985","unstructured":"Mazzanti L, Breschi MC, Giovanni L, Bertelli AA. Fluorescence in sections of cardiac muscle from rats acutely treated with 4\u2019-0-tetrahydropyranil-adriamycin hydrochloride (THP). Drugs Exp Clin Res. 1985;11(4):281\u20133.","journal-title":"Drugs Exp Clin Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2738-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-014-2738-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2738-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T11:38:18Z","timestamp":1565264298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-014-2738-2"}},"subtitle":["Targeted polymer drug conjugates for cancer diagnosis and therapy"],"short-title":[],"issued":{"date-parts":[[2014,3,19]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2738"],"URL":"https:\/\/doi.org\/10.1007\/s00259-014-2738-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,19]]}}}